Pharmacokinetics and Biochemical Effects in Responders and Non-Responders to Non-Steroidal Anti-Inflammatory Drugs
- 1 January 1981
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 10 (sup39) , 19-27
- https://doi.org/10.3109/03009748109095330
Abstract
It is now accepted that some patients will fail to respond clinically to one non-steroidal anti-inflammatory drug but will respond to another apparently similar compound (8). There are a number of possible reasons for this failure to respond such as the use of inadequate dosage or inappropriate drugs. However these reasons are unlikely to be applicable in the situation outlined above and we have been interested in exploring further, possible reasons for this failure to respond. We have therefore conducted two studies in patients with rheumatoid arthritis to examine the relationship between the pharmacokinetics of the drugs used, the clinical response to the drug, and certain biochemical effects of the drugs. The initial study with indometha-cin was reported more fully in 1979 (3) and the second study was reported more briefly in 1980 (II). This report reviews the initial study and reports on some new data in the second study.Keywords
This publication has 15 references indexed in Scilit:
- Double-blind dose-response study of indomethacin in rheumatoid arthritisEuropean Journal of Clinical Pharmacology, 1980
- Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonrespondersAnnals of the Rheumatic Diseases, 1979
- The interaction between indomethacin and probenecid; A clinical and pharmacokinetic studyClinical Pharmacology & Therapeutics, 1978
- Defective Platelet Lipid Peroxidation in Myeloproliferative Disorders: A Possible Defect of Prostaglandin SynthesisBritish Journal of Haematology, 1977
- Four new anti-inflammatory drugs: responses and variations.BMJ, 1976
- Plasma concentration of phenylbutazone and its therapeutic effect- studies in patients with rheumatoid arthritis.Published by Wiley ,1976
- Pharmacokinetics of indomethacinClinical Pharmacology & Therapeutics, 1975
- The effect of flurbiprofen [2-(2-fluoro-4-biphenylyl) propionic acid] on platelet function and blood coagulationThrombosis Research, 1974
- Flurbiprofen, a new potent inhibitor of platelet aggregationThrombosis Research, 1973
- Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.BMJ, 1967